Telomir Pharmaceuticals Statistics
Total Valuation
TELO has a market cap or net worth of $45.90 million. The enterprise value is $39.52 million.
Important Dates
The last earnings date was Monday, November 10, 2025, after market close.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TELO has 34.38 million shares outstanding. The number of shares has increased by 6.22% in one year.
| Current Share Class | 34.38M |
| Shares Outstanding | 34.38M |
| Shares Change (YoY) | +6.22% |
| Shares Change (QoQ) | +7.96% |
| Owned by Insiders (%) | 19.23% |
| Owned by Institutions (%) | 6.73% |
| Float | 17.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 6.54 |
| P/TBV Ratio | 6.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.51, with a Debt / Equity ratio of 0.01.
| Current Ratio | 17.51 |
| Quick Ratio | 17.33 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8,154.00 |
Financial Efficiency
Return on equity (ROE) is -303.19% and return on invested capital (ROIC) is -185.81%.
| Return on Equity (ROE) | -303.19% |
| Return on Assets (ROA) | -167.42% |
| Return on Invested Capital (ROIC) | -185.81% |
| Return on Capital Employed (ROCE) | -162.04% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.25M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.40% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -63.40% |
| 50-Day Moving Average | 1.47 |
| 200-Day Moving Average | 2.31 |
| Relative Strength Index (RSI) | 45.27 |
| Average Volume (20 Days) | 986,637 |
Short Selling Information
The latest short interest is 2.28 million, so 6.63% of the outstanding shares have been sold short.
| Short Interest | 2.28M |
| Short Previous Month | 1.88M |
| Short % of Shares Out | 6.63% |
| Short % of Float | 13.08% |
| Short Ratio (days to cover) | 0.59 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -11.31M |
| Pretax Income | -11.25M |
| Net Income | -11.25M |
| EBITDA | n/a |
| EBIT | -11.31M |
| Earnings Per Share (EPS) | -$0.37 |
Full Income StatementBalance Sheet
The company has $7.33 million in cash and $93,432 in debt, giving a net cash position of $7.24 million or $0.21 per share.
| Cash & Cash Equivalents | 7.33M |
| Total Debt | 93,432 |
| Net Cash | 7.24M |
| Net Cash Per Share | $0.21 |
| Equity (Book Value) | 6.98M |
| Book Value Per Share | 0.21 |
| Working Capital | 6.98M |
Full Balance SheetCash Flow
| Operating Cash Flow | -3.09M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
